Pathology and Clinical Laboratory Medicine Case Studies
Healthcare5 Case StudiesUpdated Sep 2026
Pathology and clinical laboratory work sits between the bedside and the analyzer, and much of its risk lives in the gaps: a result that arrives without context, a verbal call that nobody logs, a specimen that waits too long for a decision. The five cases below come from hospital and reference laboratory settings. Each asks what the team knew, what they could have known sooner, and which protocol should have carried the decision. Treat them as working problems rather than verdicts. Names are first names and roles only, and every organization and figure belongs to a fictional service.
Case Study 1
A rising trend that did not trigger review
Eastbrook Community Hospital, a 260-bed acute hospital with a medical admissions unit and a shared laboratory
The situation
Ruth, a staff nurse in the medical admissions unit, handed over a 67-year-old man who had arrived with three days of worsening breathlessness, intermittent fever, and a cough that had changed from dry to productive. His observations had drifted over the course of the afternoon. The admitting registrar, Dev, ordered a standard panel of blood tests, a set of cultures, and a chest image. Two hours later the white cell count was raised, the lactate was borderline, and the cultures were still in progress. The bedside team wanted to know whether the picture justified moving him to the higher dependency area or waiting for the cultures to flag.
The challenge
The difficulty was that no single result settled the question. The laboratory had sent a preliminary note that the lactate was near the threshold for review, but the protocol for escalation depended on the observation chart as well, and the chart had been completed by three different people across the shift. Ruth felt the trend was clearly upward. Dev believed the numbers were still within a range that could be managed on the ward for another few hours. Neither was careless, and both were working from partial information.
Analysis
Start with what the patient needed in the next hour, not with the full list of tests. The clinical evidence pointed in one direction: a rising inflammatory marker, a borderline lactate, and an observation trend that was moving the wrong way. None of these alone is decisive, and the team's reasoning was strongest when it treated them as a pattern over time. Repeated observations recorded at fixed intervals with one scoring tool turn a feeling into evidence another clinician can check. The laboratory's part is to report each result with its collection time, so a change between two samples stays visible.
Teams grounded in Pathology and Clinical Laboratory Medicine usually write the escalation question down before ordering the next test, because it forces agreement on the threshold that matters. Here the local early warning protocol set a score that required senior review, and the disagreement turned on whether a trend across two charts counted toward it. The protocol did not settle that point, so the decision belonged to the registrar and the charge nurse together. Dev and Ruth held different pieces of the picture and had not spoken directly since the handover. A short structured conversation at the bedside would have put both views on the same chart.
- Observe and record Repeat scored observations at fixed intervals with the same tool.
- Review results together Read the sample trend with the bedside chart, not as isolated values.
- Apply the protocol Check whether the score or the trend rule meets the trigger for review.
- Escalate or document Either call the senior review or record why the threshold was not met.
Actions taken
- Write the escalation threshold for this presentation on the observation chart itself, with the score and the trend rule, so that the next shift does not have to reconstruct it from memory.
- Require a documented bedside conversation between the registrar and the charge nurse whenever the trend rule is met but the single score is below the trigger, and record the outcome in the same entry.
- Ask the laboratory to flag any result that changes direction between two samples taken within one shift, so the ward sees the movement rather than two separate normal ranges.
- Schedule a short review of cases where the escalation decision was delayed by more than one shift, comparing timestamps for the sample, the result, and the first senior review.
Results
Over the following quarter the unit reviewed 46 admissions in which the trend rule was met without a trigger score. Once the bedside conversation became routine, the time from a second abnormal sample to documented senior review fell from roughly ninety minutes to under forty. Transfers to the higher dependency area did not rise, which suggested the earlier conversations were not simply producing more caution. The chart entries were also easier to read at handover, and two staff said the wording had prompted them to ask questions they would otherwise have carried silently.
Questions for discussion
- Which parts of the escalation decision were clinical judgment, and which parts were set by the local protocol, and how would you separate them on a busy shift?
- If the trend rule and the trigger score point in different directions, who should own the decision, and what should be documented?
- What would you need to see in the laboratory report to make a two-sample change obvious to a nurse who has not looked at the earlier result?
Case Study 2
A critical call that never reached the handover sheet
Stonebridge General Hospital, a 540-bed teaching hospital whose pathology service covers two sites
The situation
A critical chemistry result came through the laboratory's telephone line at the end of the late shift on a surgical ward. Imani, the nurse who took the call, wrote it on a scrap of paper and meant to add it to the handover sheet. She was pulled into a bed emergency during the last half hour and left at the scheduled time. The paper stayed in her pocket. The day team received a verbal summary that listed the patient's routine results and two open questions but nothing about the call. The result sat untouched for almost five hours, until a routine round found it.
The challenge
The gap was small and ordinary, which is why it was hard to see. The handover tool had no field for telephoned results, the late shift had no shared log of which calls had been taken, and the charge nurse assumed a critical call would have reached the ward doctor directly. Imani believed the call had been passed on because the doctor had been on the ward during the evening. Each person reasoned sensibly from what they had, and the paper was the only record.
Analysis
The patient needed the result acted on within the hour the laboratory released it, because a critical chemistry value means the next decision cannot wait for routine review. The evidence in this case was not ambiguous. The value was out of range, the sample had been confirmed as correctly labeled, and the call had been logged by the laboratory with a time and a receiving name. What was missing was the link from the laboratory's record to the ward's action. Safety depends on that link being visible in more than one place, so that a delay in one system shows up in another before harm occurs.
The Stonebridge critical result policy asks for three things: a read-back of the value, the name of the clinician who accepts responsibility, and an entry in the clinical record within a set period. The read-back happened during the call. The acceptance did not, because nobody had yet reached the doctor, and the record entry depended on a sheet of paper that never left the late shift. The handover tool was built for verbal summaries and had no line for results still awaiting action. Closed loop communication only works when the sender knows the message has reached the next person, and this case broke at that step.
Actions taken
- Add a required line to the handover tool for any telephoned critical result, with the caller, the time, the value, and the named clinician who has accepted it.
- Replace paper notes taken during calls with a direct entry into the laboratory request record, so the result is visible to the next shift without relying on memory or a pocket.
- Run a monthly audit of critical results measuring the minutes from release to documented acceptance, and report any result that exceeds the policy window at the ward safety meeting.
- Include the handover of pending results in the ward round for the first hour of each shift, so the day team confirms each open item with the nurse who holds it.
Results
After the tool change was piloted on the surgical ward, the time from release to documented acceptance for critical results fell from a median of about forty minutes to under ten. The pilot ran for one full quarter. The team also found eleven other results where a verbal summary had omitted a pending item, and those were corrected before any harm was recorded. The nursing staff said the single added line made the question of who had the call easier to answer at a glance. The change now covers the two medical wards as well.
Questions for discussion
- Where in your own unit does a result reach a person who is not yet responsible for acting on it, and what records that transfer?
- Which single field, if it were required on every handover, would have changed the outcome in this case, and what would it cost the day team to complete it?
- How would you test whether a new handover line is being used accurately rather than completed as a formality?
Case Study 3
A backlog that exceeded what one bench could clear
Caldwell Regional Health, a three-hospital network sharing one core laboratory and a histology unit
The situation
The core laboratory at Caldwell Regional Health handles about 6,200 specimens on a weekday, and the histology unit processes around 180 biopsy cases. Over one month, the chemistry analyzer that handles most urgent work went down for two unplanned periods, and a staffing gap left the histology bench with one fewer technologist than usual. Backlog grew to a level that the emergency department described as unusable. The laboratory director, Helen, had to decide how to ration the remaining capacity without putting urgent cases behind routine ones or delaying diagnostic reporting for cancer pathways.
The challenge
Three options were on the table, and each protected something different. Reordering the queue would favor urgent samples but lengthen waits for outpatient bloods that clinicians had already scheduled around. Sending overflow to a partner reference laboratory would relieve the bench but add transport time and a second chain of custody. Extending shifts would use existing staff, but two of the technologists had already reached the limit set by the fatigue policy. None of the options was free.
Analysis
Patient need should set the order of work before any staffing or scheduling decision. The laboratory's own priority categories tie each specimen to a clinical urgency, and the review looked at whether the queue reflected those categories. It did not. Routine outpatient samples had been moved ahead of inpatient ones because they were easier to batch, which kept the bench busy but delayed results that changed same-day management. Biopsy reports followed a different clock, and a delay there matters for treatment planning in ways that a delayed chemistry result does not. Capacity decisions are clinical decisions when the queue is the thing that determines when a clinician can act.
The laboratory's escalation policy for capacity shortfalls required the director to inform the clinical directors of the three hospitals within the first hour of a declared shortfall, and it set out the order in which work could be deferred. The policy had been written for a single analyzer outage and did not address a combined staffing and equipment problem. As a result, the decision sat with one person for most of the first day. A short daily call between laboratory leads and ward or department representatives would have shared the load and made trade-offs visible to the people who bore them.
Actions taken
- Publish the priority categories for every specimen type with the clinical reason for each, so that reordering decisions rest on a written rule rather than the judgment of whoever is on shift.
- Set a daily capacity meeting at the start of each shift with a lead from each hospital, and agree the deferral list before the bench starts, not during the afternoon.
- Agree a written partner laboratory arrangement that covers transport times, specimen stability checks, and result routing before it is needed, so overflow does not depend on phone calls during the emergency.
- Log every deferral with the specimen type, the reason, the ordering clinician, and the new expected report time, and send the list to the affected departments each afternoon.
Results
The director combined two steps: a priority reorder with a fixed cutoff for routine outpatient bloods, and overflow chemistry sent to a partner laboratory. Biopsy reporting kept its original timelines. Within a week, the share of urgent specimens reported inside the agreed window had returned to its usual level, and outpatient complaints rose only slightly. The analyzer repair was completed in the fourth week, and the combined plan held without any extension of shifts. The review recorded the trade-offs in a shared log so the next shortfall starts from a clearer position.
Questions for discussion
- When a laboratory reorders its queue, which groups of patients carry the cost of the change, and how would you find out before the decision is made?
- What would have to be true about staff fatigue and handover for extending shifts to be a safe option rather than a fast one?
- How would you decide which work to defer, and who should be told that a deferral has happened?
Case Study 4
Why specimen rejections varied across four clinics
Ashgrove Pathology Service, a hospital-based cytology and histology laboratory serving four outpatient clinics
The situation
The cytology and histology section at Ashgrove Pathology Service received about 2,800 cases a month from four outpatient clinics. Over the reporting period, the proportion of specimens rejected for inadequate labeling or transport delay varied widely between clinics, from under two percent to above nine percent. The turnaround for the same test ranged from four days to nearly two weeks depending on the site and the week. Sana, the quality lead, pulled anonymized indicators for the last two quarters and found that the variation did not track patient volume or case mix.
The challenge
The obvious explanation was staff training, and the clinics had already offered it. Training had been delivered to all four sites in the same month, yet the spread persisted. Sana needed to separate a process problem from a people problem without identifying individuals, so the review stayed at site and week level by agreement. Early looks showed that two clinics used the same request form with different collection kits, and one received courier pickups only twice a day.
Analysis
For patients, the cost of a rejected specimen is a repeat sample, a delayed diagnosis, and a second visit that may never happen. The evidence on rejection was useful because it was specific. Rejections clustered in labeling errors and in specimens older than the stability window at arrival, not in inadequate material from the clinician. That shifts the question from whether clinicians collect well to whether the path from clinic to laboratory protects what they collected. Indicators like these only help if they are read against the clinical question each test answers, so that a faster report is not mistaken for a better one.
The service's specimen handling protocol set labeling checks at collection and a maximum transport time, but it was written as a single standard for all sites and never audited at the clinic level. Coordination between the laboratory and the clinics ran through a shared mailbox, so a rejection notice might reach a clinic days after the specimen was lost to the process. A plan-do-study-act cycle fits this kind of problem because it limits each change to one site and one week, and it forces the team to write down what they expected to happen before the change is made.
- 1Map the pathwayTrace each handoff from collection to accession at every clinic.
- 2Find likely causesGroup rejections by reason, site, and week before assuming training gaps.
- 3Test one changeRun a single contained change at one site for four weeks.
- 4Monitor the indicatorTrack weekly rejection rate and turnaround against the agreed baseline.
- 5Adopt, adjust, or stopDecide on the evidence, then standardize or withdraw the change.
Actions taken
- Map the path from collection to accession for each clinic, marking every handoff, storage point, and courier interval, and check the map with the staff who perform each step.
- Agree a single rejection code list and a weekly report by site, with the rejection reason recorded for every returned specimen, so the indicator measures the same thing everywhere.
- Test one change at one clinic for four weeks, such as a labeling check at the point of collection, and write the expected effect on rejections before the first specimen is sent.
- Hold a review at the end of each cycle with the laboratory and clinic leads, decide whether to adopt, adjust, or stop the change, and publish the decision with its evidence.
Results
The first cycle ran at the clinic with the highest rejection rate. The labeling check at collection cut rejections there by roughly half over the four weeks, while the other sites stayed where they had been. The team then tested the courier change at a second site, which reduced transport delays but did not change rejections. The review concluded that labeling was the main driver at one clinic and transport was the driver at another, so one standard could not fit all four. The service now runs site-specific changes under the same monitored template.
Questions for discussion
- Which of the four indicators in this review would you trust least, and what would you check before using it to judge a site?
- How would you keep a site-specific change from quietly becoming a permanent exception that nobody reviews?
- What would convince a clinic lead that a rejection problem sits in the process rather than in their own collection practice?
Case Study 5
A finding that touched more people than the patient
Greycliff Health Partners, a community hospital group with a shared pathology service and a patient liaison office
The situation
A woman in her forties had a tissue sample taken during an outpatient review. The pathology report included a finding that was not the reason for the referral, and it had implications for her adult children and siblings. She had told the clinic nurse, Tomasz, that she did not want her family to know anything until she had decided how to tell them. Her referring doctor, Priya, wanted the result shared with the family's primary care clinic so that a relative could be advised. The pathologist, Gareth, had to decide what to release and to whom.
The challenge
The patient had a right to control how her own information was shared, and she had stated that clearly in the chart. The relatives might face a decision about their own monitoring that could be affected by the information, and the referring team felt they should not be left uninformed. Gareth could not verify the family's situation, and Priya's request came with a note that the patient's wishes were not yet in the laboratory system. The choice was not between telling everyone and telling no one.
Analysis
The patient needed to understand what the finding meant for her before anyone spoke to her family, and she needed that conversation to happen at a pace she could manage. The clinical evidence was solid as far as the report went, but it did not establish what the finding meant for relatives. That required a specialist review and a written summary that separated what was known from what was uncertain. The pathologist's role was to report the finding accurately and to flag its potential relevance to others, not to decide who should be told. That order protects both the patient and her relatives.
The local consent and confidentiality policy allowed disclosure to a clinician involved in care without the patient's explicit agreement, but it required the patient to be told that disclosure was intended and why. The referring team acted in good faith, but the request went to the family's clinic before the patient had been seen by a clinician who could explain the finding. The protocol had a clear escalation route: the pathology consultant on duty, then the clinical governance lead, then the medical director if the disagreement persisted. Using that route would have put the decision on record and kept the nurse, Tomasz, from carrying an unresolved conflict alone.
- Day of reportingFinding recorded, with the patient's earlier request noted in the file.
- Two days laterReferring team asks for release to the family's clinic.
- Within the first weekConsultant summary written and reviewed with the patient in person.
- After one more weekUnresolved disagreement escalated to clinical governance with a written record.
- When wishes are recordedAgreed disclosure made to the family clinic, limited to the stated scope.
Actions taken
- Confirm with the patient, in a private conversation and with a note in the record, what she is willing to have shared, with whom, and by when, before any letter or call is made.
- Ask the pathology consultant to write a short summary that states the finding, its uncertainty, and its possible relevance to relatives, so the referring team works from one document.
- Record the request from the family's clinic as pending, and do not release the report to that clinic until the patient's stated wishes are entered in the laboratory system.
- Escalate the disagreement through the clinical governance lead if the referring team and the patient's wishes still conflict after one week, and document each step in the record.
Results
The patient was seen by the consultant in the second week and asked for a limited disclosure: her sister was to be told only that a further review was recommended, and her children were to hear the full picture from her directly. The record was updated and the laboratory system matched the wishes. The family's clinic received a letter with the limited wording, and the referring team confirmed that the relative's review had been arranged. The case was logged for review and the policy was revised to require a named clinician for each disclosure involving relatives.
Questions for discussion
- What is the difference between a patient agreeing to a disclosure and a patient understanding what the disclosure will mean for someone else, and how would you check for both?
- If a relative's health could be affected by a finding, what duty do the laboratory and the referring team each hold, and where does that duty stop?
- Which records should show that a limited disclosure was agreed, and who should be able to see them later?
Learning Resources
Healthcare CASE STUDIES
China, India, United States, Indonesia, Pakistan, Nigeria, Brazil, Bangladesh, Russia, Japan, Mexico, Philippines, Vietnam, Egypt, Turkey, Germany, United Kingdom, France, Italy, Canada, South Korea, Australia, Spain.